Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex

Biomaterials

Volumn 32, Issue 25, 2011, Pages 5889-5899

  Aldawsari, Hibah ^a   Edrada Ebel, RuAngelie ^a   Blatchford, David R ^a   Tate, Rothwelle J ^a   Tetley, Laurence ^b   Dufès, Christine ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Amino acid; Dendrimer; DNA; Gene expression; Nanoparticles

Indexed keywords

AFTER-TREATMENT; ANTI-PROLIFERATIVE; CANCER CELLS; ENHANCED GENE EXPRESSION; GENE DELIVERY SYSTEMS; GENE EXPRESSION LEVELS; GENE TRANSFECTION; IN-VITRO; IN-VIVO; INTRAVENOUS ADMINISTRATION; NON-VIRAL GENE DELIVERY; POLYPLEXES; POLYPROPYLENIMINE; VIRAL SYSTEMS;

ARGININE; BEARINGS (STRUCTURAL); CELLS; DENDRIMERS; DISEASES; GENE THERAPY; GENE TRANSFER; NUCLEIC ACIDS; TUMORS;

GENE EXPRESSION;

ARGININE; DENDRIMER; DIAMINOBUTYRIC POLYPROPYLENIMINE DENDRIMER; LEUCINE; LYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL TRANSPORT; CONJUGATION; CONTROLLED STUDY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; ARGININE; FEMALE; GENE EXPRESSION; HUMANS; LEUCINE; LYSINE; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; NEOPLASMS; POLYPROPYLENES;

EID: 79957913004     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.079     Document Type: Article

References (26)

1. Luo D., Saltzman W.M. Synthetic DNA delivery systems. Nat Biotechnol 2000, 18:33-37.
2. Li S.D., Huang L. Non-viral is superior to viral gene delivery. J Control Release 2007, 123:181-183.
3. Dufès C., Uchegbu I.F., Schätzlein A.G. Dendrimers in gene delivery. Adv Drug Deliv Rev 2005, 57:2177-2202.
4. Dufès C., Keith W.N., Bisland A., Proutski I., Uchegbu I.F., Schätzlein A.G. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res 2005, 65:8079-8084.
5. Koppu S., Oh Y.J., Edrada-Ebel R., Blatchford D.R., Tetley L., Tate R.J., et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. J Control Release 2010, 143:215-221.
6. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002, 245:1-7.
7. Nakanishi M., Eguchi A., Akuta T., Nagoshi E., Fujita S., Okabe J., et al. Basic peptides as functional components of non-viral gene transfer vehicles. Curr Prot Pept Sci 2003, 4:141-150.
8. Choi J.S., Nam K., Park J.Y., Kim J.B., Lee J.K., Park J.S. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release 2004, 99:445-456.
9. Tung C.H., Weissleder R. Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev 2003, 55:281-294.
10. Gao Y., Xu Z., Chen S., Gu W., Chen L., Li Y. Arginine-chitosan / DNA self-assemble nanoparticles for gene delivery: in vitro characteristics and transfection efficiency. Int J Pharm 2008, 359:241-246.
11. Kono K., Akiyama H., Takahashi T., Takagishi T., Harada A. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconjug Chem 2005, 16:208-214.
12. Kim T.I., Baek J.U., Bai C.Z., Park J.S. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials 2007, 28:2061-2067.
13. Kim T.I., Ou M., Lee M., Kim S.W. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 2009, 30:658-664.
14. Aldawsari H., Sundara Raj B., Edrada-Ebel R., Blatchford D.R., Tate R.J., Tetley L., et al. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex. Nanomedicine: NBM 2011, 10.1016/j.nano.2011.01.016.
15. Fu J.Y., Blatchford D.R., Tetley L., Dufès C. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles. J Control Release 2009, 140:95-99.
16. Zinselmeyer B.H., Mackay S.P., Schätzlein A.G., Uchegbu I.F. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res 2002, 19:960-967.
17. Zinselmeyer B.H., Beggbie N., Uchegbu I.F., Schätzlein A.G. Quantification of beta-galactosidase activity after non-viral transfection in vivo. J Control Release 2003, 91:201-208.
18. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995, 55:3752-3756.
19. Mahato R.I., Smith L.C., Rolland A. Pharmaceutical perspectives of nonviral gene therapy. Adv Genet 1999, 41:95-156.
20. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 2001, 12:1005-1011.
21. Nam H.Y., Nam K., Hahn H.J., Kim B.H., Lim H.J., Kim H.J., et al. Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity. Biomaterials 2009, 30:665-673.
22. Kurisawa M., Yokoyama M., Okano T. Transfection efficiency increases by incorporating hydrophobic monomer units into polymeric gene carriers. J Control Release 2000, 68(1):1-8.
23. Schätzlein A.G., Zinselmeyer B.H., Elouzi A., Dufès C., Chim Y.T.A., Roberts C.J., et al. Preferential liver gene expression with polypropylenimine dendrimers. J Control Release 2005, 101:247-258.
24. Barron L.G., Gagne L., Szoka F.C. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum Gene Ther 1999, 10:1683-1694.
25. Fujita T., Furuhata M., Hattori Y., Kawakami H., Toma K., Maitani Y. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. J Control Release 2008, 129:124-127.
26. Kim H.S., Song I.H., Kim J.C., Kim E.J., Jang D.O., Park Y.S. In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O, O'-dimyristyl-N-lysyl aspartate) and DMKE (O, O'-dimyristyl-N-lysyl glutamate). J Control Release 2006, 115:234-241.